Sentences with phrase «cancer society study»

A large American Cancer Society study found that men with prostate cancer who exercised the most were 30 percent less likely to die from the disease than those who exercised the least.

On 1 August, the panel voted along party lines to approve a subpoena for raw data from the Harvard Six Cities Study and an American Cancer Society study known as «Cancer Prevention Study II.»

A new American Cancer Society study shows that uninsured adolescents and young adults were far more likely to be diagnosed with late - stage cancer, which is more difficult and expensive to treat and more deadly, compared to young patients with health insurance.

Not exact matches

Dr. Clifford A. Hudis, Chief Executive Officer, American Society of Clinical Oncology Greg Simon, Executive Director, Cancer Moonshot Task Force, The White House Dr. Ken Robert Smith, Distinguished Professor of Family Studies and Population Science; Director, Utah Population Database, University of Utah Moderator: Clifton Leaf, Fortune

Notes to Editors The report, «How alcohol industry organisations mislead the public about alcohol and cancer», by Mark Petticrew, Nason Maani Hessari, Cécile Knai and Elisabete Weiderpass, will be published online in Drug and Alcohol Review at 22:00 6 September 2017 The Institute of Alcohol Studies is an independent institute bringing together evidence, policy and practice from home and abroad to promote and informed debate on alcohol's impact on society.

The new research, published recently as two separate studies in ACS Central Science and the Journal of the American Chemical Society, demonstrates that a new class of drugs called small molecule RNA inhibitors can successfully target and kill specific types of cancer.

Published early online in CANCER, a peer - reviewed journal of the American Cancer Society, the study also revealed significant racial differences in the risk of dying from cervical cCANCER, a peer - reviewed journal of the American Cancer Society, the study also revealed significant racial differences in the risk of dying from cervical cCancer Society, the study also revealed significant racial differences in the risk of dying from cervical cancercancer.

This study will be presented at the European Society for Medical Oncology World Conference on Gastrointestinal Cancer being held June 25 - 28 in Barcelona, Spain.

«Taxing sugary drinks isn't a new concept, but given the immediacy of the global obesity problem, it's time we got creative with how we approach it,» said author of the study Dr. Evan Blecher, Senior Economist at the American Cancer Society.

In a trio of studies to be presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, investigators at Dana - Farber Cancer Institute will present the results of clinical trials showing that new drug combinations can significantly extend the time in which multiple myeloma is kept in check in patients with relapsed or treatment - resistant forms of the disease.

Otis Brawley, a medical oncologist and chief medical officer of the American Cancer Society who was not involved with the study, says, «It certainly adds to the body of evidence, but it's by no means definitive.»

People diagnosed with cancer gained 3.34 million years of life thanks to cancer clinical trials run by SWOG and supported with public funds, according to new study results to be presented at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), the world's largest clinical cancer research meeting.

But a study of mice shows that breast cancer cells decamp in groups, and the clumps of cells have a better chance of establishing a colony than loners do, Kevin Cheung of Johns Hopkins University reported December 7 at the annual meeting of the American Society for Cell Biology.

Since the last American Cancer Society (ACS) breast cancer screening update for average - risk women was published in 2003, new evidence has accumulated from long - term follow - up of randomized controlled trials and observational studies of organized, population - based screening proCancer Society (ACS) breast cancer screening update for average - risk women was published in 2003, new evidence has accumulated from long - term follow - up of randomized controlled trials and observational studies of organized, population - based screening procancer screening update for average - risk women was published in 2003, new evidence has accumulated from long - term follow - up of randomized controlled trials and observational studies of organized, population - based screening programs.

For the current study, Binh T. Nguyen of the American Cancer Society and Lisa M. Powell of the University of Illinois at Chicago used more recent data from more than 12,000 respondents between the ages of 20 and 64 taking part in the National Health and Nutrition Examination Survey 2003 (NHANES).

«Our study shows that protein production in neurons is one of the major utilizers of energy and that neurons of Leigh syndrome degenerate because they can't sustain a high enough level of energy,» says Tony Hunter, the Renato Dulbecco Chair and American Cancer Society Professor in Salk's Molecular and Cell Biology Laboratory, who led the research.

«We know from previous research that lack of insurance typically results in diagnosis of cancer at a later, and usually less treatable, stage,» said lead study author Xuesong Han, PhD, Strategic Director, Health Policy and Healthcare Delivery Research, American Cancer Socancer at a later, and usually less treatable, stage,» said lead study author Xuesong Han, PhD, Strategic Director, Health Policy and Healthcare Delivery Research, American Cancer SoCancer Society.

A new study published early online in CANCER, a peer - reviewed journal of the American Cancer Society, provides some insights and may help physicians understand patients» preferences regarding their care.

A comprehensive analysis of the study's results — published in June 1 online edition of the New England Journal of Medicine and to be presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago — found participants treated with enzalutamide saw an 81 percent reduction in the risk the cancer would progress and a 29 percent reduction in the risk of death.

Sylvia Adams, MD, associate professor of medical oncology at Perlmutter Cancer Center and principal investigator of this study, presented the findings on June 3 in Chicago at the annual meeting of the American Society of Clinical Oncology.

For the current study, scientists led by Helmneh Sineshaw, M.D., MPH, analyzed data from 260,174 breast cancer cases recorded in the National Cancer Data Base (NCDB), a national hospital - based cancer registry database jointly sponsored by the American College of Surgeons and the American Cancer Socancer cases recorded in the National Cancer Data Base (NCDB), a national hospital - based cancer registry database jointly sponsored by the American College of Surgeons and the American Cancer SoCancer Data Base (NCDB), a national hospital - based cancer registry database jointly sponsored by the American College of Surgeons and the American Cancer Socancer registry database jointly sponsored by the American College of Surgeons and the American Cancer SoCancer Society.

For their study, researchers led by Anthony Robbins, M.D., Ph.D., American Cancer Society director of health services research, analyzed data from nearly 260,000 cancer patients ages 15 to 39 in the National Cancer DatCancer Society director of health services research, analyzed data from nearly 260,000 cancer patients ages 15 to 39 in the National Cancer Datcancer patients ages 15 to 39 in the National Cancer DatCancer Database.

«Cancer constitutes an enormous burden to society, and both cancer and heart failure are well - known causes of increased mortality,» said Veronique Roger, M.D., senior author of the study and director of the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery in Rochester, MinnCancer constitutes an enormous burden to society, and both cancer and heart failure are well - known causes of increased mortality,» said Veronique Roger, M.D., senior author of the study and director of the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery in Rochester, Minncancer and heart failure are well - known causes of increased mortality,» said Veronique Roger, M.D., senior author of the study and director of the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery in Rochester, Minnesota.

These studies estimate mammography decreases the number of deaths by anywhere from 35 percent to 0 percent, says Otis Brawley, chief medical officer at the American Cancer Society.

For the retrospective, population - based study, the researchers used the National Cancer Database (NCDB), a nation - wide outcomes registry of the American College of Surgeons, the American Cancer Society and the Commission on Cancer that captures approximately 70 percent of newly - diagnosed cases of cancer in the coCancer Database (NCDB), a nation - wide outcomes registry of the American College of Surgeons, the American Cancer Society and the Commission on Cancer that captures approximately 70 percent of newly - diagnosed cases of cancer in the coCancer Society and the Commission on Cancer that captures approximately 70 percent of newly - diagnosed cases of cancer in the coCancer that captures approximately 70 percent of newly - diagnosed cases of cancer in the cocancer in the country.

Women diagnosed with polycystic ovary syndrome — the most common hormone disorder in women of reproductive age — face a heightened risk of developing heart disease, diabetes, mental health conditions, reproductive disorders and cancer of the lining of the uterus than healthy women, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

The results, which are presented today at the 30th Annual Meeting of ESHRE in Munich by Dr Allan Jensen of the Danish Cancer Society Research Center at the University of Copenhagen, were derived from a register study of all children born in Denmark between 1969 and 2006.

Published early online in CANCER, a peer - reviewed journal of the American Cancer Society, the study found that factors such as gender, education, and insurance status may impact whether patients and their physicians have discussions and take actions to preserve fertility during cancer treaCANCER, a peer - reviewed journal of the American Cancer Society, the study found that factors such as gender, education, and insurance status may impact whether patients and their physicians have discussions and take actions to preserve fertility during cancer treaCancer Society, the study found that factors such as gender, education, and insurance status may impact whether patients and their physicians have discussions and take actions to preserve fertility during cancer treacancer treatment.

The study was published in the December issue of Experimental Hematology, the official publication of the Society for Hematology and Stem Cells, and also highlighted in the journal's editorial due to its significance in the biology and treatment of blood cancer.

The strategy is described in a study published early online in Cancer, a peer - reviewed journal of the American Cancer Society.

To investigate the association of smoking, before and after diagnosis, with all - cause and colorectal cancer - specific mortality among colorectal cancer survivors, researchers led by Dr. Peter Campbell identified 2,548 people newly diagnosed with invasive, non-metastatic colorectal cancer from among 184,000 adults in the American Cancer Society's Cancer Prevention Stucancer - specific mortality among colorectal cancer survivors, researchers led by Dr. Peter Campbell identified 2,548 people newly diagnosed with invasive, non-metastatic colorectal cancer from among 184,000 adults in the American Cancer Society's Cancer Prevention Stucancer survivors, researchers led by Dr. Peter Campbell identified 2,548 people newly diagnosed with invasive, non-metastatic colorectal cancer from among 184,000 adults in the American Cancer Society's Cancer Prevention Stucancer from among 184,000 adults in the American Cancer Society's Cancer Prevention StuCancer Society's Cancer Prevention StuCancer Prevention Study II.

For their new study, researchers led by Lee Westmaas examined psychological correlates of smoking status and patterns, likelihood of quitting, and intentions to quit among long - term survivors enrolled in the American Cancer Society's Study of Cancer Survivors - I (SCS - I), a longitudinal nationwide study of adult survivors of 10 commonly diagnosed canstudy, researchers led by Lee Westmaas examined psychological correlates of smoking status and patterns, likelihood of quitting, and intentions to quit among long - term survivors enrolled in the American Cancer Society's Study of Cancer Survivors - I (SCS - I), a longitudinal nationwide study of adult survivors of 10 commonly diagnosed canStudy of Cancer Survivors - I (SCS - I), a longitudinal nationwide study of adult survivors of 10 commonly diagnosed canstudy of adult survivors of 10 commonly diagnosed cancers.

The findings come from a new study by American Cancer Society researchers, one of the largest studies of smoking and colorectal cancer survival and the first study to prospectively collect both pre - and post-diagnosis smoking informCancer Society researchers, one of the largest studies of smoking and colorectal cancer survival and the first study to prospectively collect both pre - and post-diagnosis smoking informcancer survival and the first study to prospectively collect both pre - and post-diagnosis smoking information.

Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers at Dana - Farber Cancer Institute have found in a study presented at the annual meeting of the American Society of Hematology (ASH).

The findings of multiple in vivo preclinical studies published online in Blood Advances, a Journal of the American Society of Hematology (ASH), indicate that this therapy could potentially treat multiple cancers, including non-Hodgkin lymphoma (NHL), multiple myeloma (MM), and acute myeloid leukemia (AML).

Researchers from Sanford Health and Chronix Biomedical today announced that results from a pilot study demonstrating the utility of a new cancer panel to detect previously undetected viral and cancer mutations are to be reported in a poster presentation titled «Detection of novel HPV mutations and chromosomal number imbalance (CNI) in oropharyngeal and laryngeal cancer using next - generation sequencing (NGS)» at the American Society of Clinical Oncology Annual Meeting (ASCO 2014) being held from May 30 through June 3, 2014 in Chicago.

«Our findings reveal that a high degree of future orientation appears to be protective against eating frequently at fast food establishments,» said Kerem Shuval, PhD, of the American Cancer Society, lead author of the study.

To investigate further, researchers from the American Cancer Society along with colleagues at the University of California, Irvine, University of Massachusetts, Amherst, and the Gretchen Swanson Center for Nutrition, embarked on this study to identify factors that affect away - from - home eating.

A new University of Colorado Cancer Center study being presented today at the Endocrine Society Annual Meeting shows that even triple negative breast cancers expressing very low levels of androgen receptor may benefit from this therapy.

These didn't include raw data from either of the two major studies in question — one known as the Harvard Six Cities Study and the other by the American Cancer Society (ACS).

A study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) describes the results of a phase I clinical trial of the investigational agent DMOT4039A against pancreatic and ovarian cancers.

The study was financed by the Lars Hierta Memorial Foundation, the Mary Béve Foundation for Childhood Cancer Research, the Anna - Brita and Bo Castegren Memorial Foundation, the Swedish Cancer Society, the Swedish Research Council, the Swedish Childhood Cancer Foundation, the King Gustaf V's Jubilee Fund and Karolinska Institutet.

It turns out people in all three groups sleep no more than those of us in industrialized nations: A landmark study in 2002 of data from the American Cancer Society on more than 2 million people found that most sleep 6.5 to 7.5 hours a night, on average.

For the new study, investigators led by Helmneh Sineshaw, M.D., MPH, at the American Cancer Society with collaborators from Dana - Farber Cancer Institute at Harvard Medical School, focused on the impact of access to care on black - white survival disparity.

For women undergoing breast cancer surgery, a technique called lipofilling — using the patient's own fat cells to optimize the results of breast reconstruction — does not increase the risk of recurrent breast cancer, reports a study in the February issue of Plastic and Reconstructive Surgery ®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Those findings are among results of six studies of investigational chimeric antigen receptor (CAR) T cells for both adult and pediatric leukemias, adult lymphomas, and ovarian cancer which will be presented during the 2016 American Society of Clinical Oncology Annual Meeting.

Breast density may not be a strong independent factor for breast cancer risk, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

In a presentation of early clinical trial data to the 20th Annual Scientific Meeting of the Society for Neuro - Oncology, physician scientists from the University of New Mexico Comprehensive Cancer Center reported that a large number of study participants responded well to the drug combination.

The study results were published online June 1 by the journal Breast Cancer Research and Treatment, and were presented June 4 at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

His postdoctoral studies at Kansas State University were supported by an American Cancer Society fellowship.